Philip Morton

Chief Technology Officer • Albumedix

Philip Morton has a strong technology background with over 25 years of experience in the biopharmaceutical industry, working across process and product development, and product application research. As the Chief Technology Officer of Albumedix, Dr Morton leads a team of specialists to refine recombinant albumin technologies and harness the multifaceted protein that is albumin. 


Also speaking

Stephen Sullivan

Chief Operating Officer • iPSirius

Diego Bochicchio

Director of Quality, Compliance & Regulatory EU • CAI – Commissioning Agents Inc

Eric Strati

Chief Executive Officer • Gift of Life Biologics

Event Info


2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.